# Effect of the Molecular Weight of Oat β-glucan on Its Ability to Lower Serum Cholesterol

> **NCT00981981** · PHASE2 · COMPLETED · sponsor: **Glycemic Index Laboratories, Inc** · enrollment: 367 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DIETARY_SUPPLEMENT:** Wheat bran
- **DIETARY_SUPPLEMENT:** 3g high MW
- **DIETARY_SUPPLEMENT:** 4g medium MW
- **DIETARY_SUPPLEMENT:** 3g medium MW
- **DIETARY_SUPPLEMENT:** 4g low MW

## Key facts

- **NCT ID:** NCT00981981
- **Lead sponsor:** Glycemic Index Laboratories, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-07
- **Final completion:** 2009-08
- **Target enrollment:** 367 (ACTUAL)
- **Last updated:** 2011-06-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00981981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00981981, "Effect of the Molecular Weight of Oat β-glucan on Its Ability to Lower Serum Cholesterol". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00981981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*